COVERSYL PLUS

This brand name is authorized in Australia, Brazil, Canada, Ireland, Malta, Netherlands, Nigeria, Singapore, South Africa, Turkey.

Active ingredients

The drug COVERSYL PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 1964X464OJ - PERINDOPRIL ERBUMINE
 

Perindopril is an inhibitor of the enzyme that converts angiotensin I into angiotensin II (Angiotensin Converting Enzyme ACE). The converting enzyme, or kinase, is an exopeptidase that allows conversion of angiotensin I into the vasoconstrictor angiotensin II as well as causing the degradation of the vasodilator bradykinin into an inactive heptapeptide. Inhibition of ACE results in a reduction of angiotensin II in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone. Since ACE inactivates bradykinin, inhibition of ACE also results in an increased activity of circulating and local kallikrein-kinin systems (and thus also activation of the prostaglandin system).

 
Read more about Perindopril
2
UNII F089I0511L - INDAPAMIDE
 

Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.

 
Read more about Indapamide

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 COVERSYL PLUS Tablet MPI, Generic Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09BA04 Perindopril and diuretics C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BA ACE inhibitors and diuretics
Discover more medicines within C09BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 2190G, 2845R
BR Câmara de Regulação do Mercado de Medicamentos 531301901114310, 531301902110319
CA Health Products and Food Branch 02246568, 02246569, 02321653
IE Health Products Regulatory Authority 19415, 19505, 19512
MT Medicines Authority MA066/00305, MA066/01802
NG Registered Drug Product Database B4-4159
Switch country to Nigeria in order to find specific presentations of COVERSYL PLUS
NL Z-Index G-Standaard, PRK 85146, 90093
SG Health Sciences Authority 10825P, 13633P, 13634P, 13823P
TR İlaç ve Tıbbi Cihaz Kurumu 8699552010562, 8699552090472, 8699552090489
ZA Health Products Regulatory Authority 33/7.1.3/0363, 42/7.1.3/0167

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.